Related Experiment Video
Updated: Feb 28, 2026

11:20
Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
Published on: June 14, 2021
4.4K
Phacoemulsification and Core Vitrectomy in Fuchs' Heterochromic Uveitis
Sadullah Keles1, Osman Ondas1, Orhan Ates1
1Department of Ophthalmology, Atatürk University School of Medicine, Erzurum, Turkey.
The Eurasian Journal of Medicine
|June 23, 2017
Summary
Phacoemulsification with posterior capsulorhexis, core vitrectomy, and ciliary sulcus intraocular lens (IOL) implantation is a safe and effective treatment for Fuchs
Area of Science:
- Ophthalmology
- Uveitis Management
- Cataract Surgery Techniques
Background:
- Fuchs' heterochromic uveitis (FHU) can cause visually significant cataracts.
- Standard cataract surgery may be complicated by vitreous abnormalities in FHU patients.
- Effective surgical strategies are needed to manage FHU-associated cataracts.
Purpose of the Study:
- To evaluate the efficacy and safety of a combined surgical approach for cataracts in FHU.
- To assess visual outcomes and complications of phacoemulsification with posterior capsulorhexis, core vitrectomy, and ciliary sulcus IOL implantation in FHU.
Main Methods:
- Retrospective study of 18 eyes from 18 FHU patients undergoing cataract surgery.
- Procedure included phacoemulsification, posterior capsulorhexis, core vitrectomy, and PMMA IOL implantation in the ciliary sulcus.
- Patients selected based on intraoperative assessment of vitreous haziness (+2 or more).
Main Results:
- No intraoperative complications except minor iris bleeding in 7 eyes.
- No severe postoperative intraocular inflammation observed.
- All patients achieved logMAR visual acuity of 0.05 or better post-suture removal.
- Glaucoma developed in 2 patients; suture-induced astigmatism was a short-term issue.
Conclusions:
- Combined phacoemulsification, posterior capsulorhexis, core vitrectomy, and ciliary sulcus IOL implantation is safe for FHU cataracts.
- Removal of hazy vitreous contributes to good visual outcomes in FHU patients.
- This technique offers a viable surgical option for managing complex cataracts in FHU.
Related Concept Videos
Angle Closure Glaucoma: Treatment
1.4K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.4K
Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Glaucoma: Overview
1.5K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.5K
Focusing of Light in the Eye
6.7K
Light rays enter the eye through the cornea, a transparent dome-shaped tissue that is the eye's outermost layer. The cornea bends or refracts, light rays traveling to the pupil. The shape of the cornea determines how much of the light is bent and whether the image will be focused correctly on the retina at the back of the eye. Once the light has passed through both refraction layers, it converges into a single focal point onto a small area. This is where photoreceptors start transforming...
6.7K
Ophthalmic Drug Delivery Systems
97
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
97

